SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer · Study

ArticleShelves

ArticleUpdated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer

Peter S Hall2011

OA

Articlegreen2011

Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer

Peter S Hall · Claire T. Hulme · Christopher J. McCabe · Yemi Oluboyede · Jeff A. Round · David Cameron

56 citations·0/0 files stored·PharmacoEconomics

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Health Systems, Economic Evaluations, Quality of Life HER2/EGFR in Cancer Research Economic and Financial Impacts of Cancer

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 56 citations exist upstream.

References

2006Decision Modelling For Health Economic Evaluation 1993Markov Models in Medical Decision Making 2000Handling Uncertainty in Cost-Effectiveness Models 2004HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis 2007Health related quality of life in different states of breast cancer 2005The Impact of Chronic Heart Failure on Health-Related Quality of Life Data Acquired in the Baseline Phase of the CARE-HF Study 2007Cost Effectiveness of Adjuvant Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer 2007Cost‐effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2‐positive breast cancer

Cited by

2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force 2014Cost-effectiveness analysis of 3D image-guided brachytherapy compared with 2D brachytherapy in the treatment of locally advanced cervical cancer

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Forcearticle · 5 shared references 2019Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancerarticle · 5 shared references 2007Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancerarticle · 4 shared references 2011Economic Evaluation of Genomic Test–Directed Chemotherapy for Early-Stage Lymph Node–Positive Breast Cancerarticle · 4 shared references 2012Cost effectiveness of gene expression profiling for early stage breast cancerarticle · 4 shared references 2014Is Individualized Medicine More Cost-Effective? A Systematic Reviewreview · 4 shared references

Details

Year2011

Typearticle

Published2011-04-20

VenuePharmacoEconomics

ISSN-L1170-7690

Languageen

Citations56

Files0 public / 0

ShelfHealth Systems, Economic Evaluations, Quality of Life

Identifiers

doi10.2165/11588340-000000000-00000

openalex_workW2084572083

Links

Imported from OpenAlex (CC0) — nothing here is generated.